World Journal of Gastrointestinal Endoscopy - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 1855452

Number of visits today: 11

Number of downloads: 1044569

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Gong T, Cheng R, Wang X, Li J, Liang W, Wei Z, Shuang S, Wang Y, Guo R. Supramolecular-interaction-mediated aggregation of anticarcinogens on triformyl cholic acid-functionalized Fe ₃ O ₄ nanoparticles and their dual-targeting treatment for liver cancer. New J Chem 2021;45:6880-8. [DOI: 10.1039/d1nj00248a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]

For:

Gong T, Cheng R, Wang X, Li J, Liang W, Wei Z, Shuang S, Wang Y, Guo R. Supramolecular-interaction-mediated aggregation of anticarcinogens on triformyl cholic acid-functionalized Fe ₃ O ₄ nanoparticles and their dual-targeting treatment for liver cancer. New J Chem 2021;45:6880-8. [DOI: 10.1039/d1nj00248a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]

Number	Citing Articles
1	Espinoza MJC, Lin KS, Weng MT, Kunene SC, Lin YS, Lin YT. Synthesis and characterization of silica nanoparticles from rice ashes coated with chitosan/cancer cell membrane for hepatocellular cancer treatment. Int J Biol Macromol 2023;228:487-97. [PMID: 36581030 DOI: 10.1016/j.ijbiomac.2022.12.235] [Reference Citation Analysis]
2	Fan B, Li Q, Jiang Y, Shen W, Xing Y, Liang G, Wu Q, Ban S, Zhang R. Development of carrier-free nanodrugs based on low molecular weight heparin–doxorubicin conjugate assembly with smart pH-triggered drug release characteristics for combinatorial antitumor therapy. New J Chem 2022;46:820-31. [DOI: 10.1039/d1nj04224f] [Reference Citation Analysis]
3	Wang X, Ma Q, Wen C, Gong T, Li J, Liang W, Li M, Wang Y, Guo R. Folic acid and deoxycholic acid derivative modified Fe₃O₄ nanoparticles for efficient pH-dependent drug release and multi-targeting against liver cancer cells. RSC Adv 2021;11:39804-39812. [DOI: 10.1039/d1ra05874f] [Cited by in F6Publishing: 1] [Reference Citation Analysis]